Full Papers
Epidemiological, pharmacological and sociodemographic characterisation of a population of 386 fibromyalgic patients referred to a tertiary pain centre in Italy
A. Martini1, V. Schweiger2, G. Del Balzo3, G. Sartori4, M. Parolini5, E. Chinellato6, P. Sarzi-Puttini7, E. Polati8
- Department of Surgery, Dentistry, Maternal and Infant Sciences, Pain Therapy Centre, Verona University Hospital, Policlinico GB Rossi, Verona, Italy. alvise.martini@univr.it
- Department of Surgery, Dentistry, Maternal and Infant Sciences, Pain Therapy Centre, Verona University Hospital, Policlinico GB Rossi, Verona, Italy.
- Department of Medicine and Public Health, Section of Forensic Medicine, Verona University Hospital, Policlinico GB Rossi, Verona, Italy.
- Department of Surgery, Dentistry, Maternal and Infant Sciences, Pain Therapy Centre, Verona University Hospital, Policlinico GB Rossi, Verona, Italy.
- Department of Surgery, Dentistry, Maternal and Infant Sciences, Pain Therapy Centre, Verona University Hospital, Policlinico GB Rossi, Verona, Italy.
- School of Science and Engineering, Middlesex University, London, UK.
- Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
- Department of Surgery, Dentistry, Maternal and Infant Sciences, Pain Therapy Centre, Verona University Hospital, Policlinico GB Rossi, Verona, Italy.
CER11057
2019 Vol.37, N°1 ,Suppl.116
PI 0027, PF 0038
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 30183596 [PubMed]
Received: 20/12/2017
Accepted : 05/03/2018
In Press: 29/08/2018
Published: 08/02/2019
Abstract
Fibromyalgia’s prevalence in Italy is about 4%. Apart from widespread pain and the three main conditions related to fibromyalgia that are included in its diagnosis (fatigue, unrefreshing sleep and cognitive disorders disturbances), there are a number of minor symptoms that have been associated to fibromyalgia. The current study aimed to characterise fibromyalgic patients referring to a single tertiary pain centre not only for sociodemographic data, but also with special attention on pharmacological history and “minor” symptoms. “Minor” refers to the group of symptoms that were frequently associated and reported with fibromyalgia in various epidemiological studies but are not required for diagnosis. A retrospective analysis was made on 386 patients with confirmed diagnosis based on the 2010 modified criteria. Our results partially confirmed known sociodemographic data, but the prevalence of some “minor” symptoms are impressively high in our population.